Anti-Mullerian Hormone and Collagen Type I C-telopeptide Predict Fast, Imminent Bone Loss in Early Perimenopause: SWAN
Combining AMH and CTX affords stronger prediction of fast, imminent BMD loss than using AMH or CTX individually.
Authors
- Sherri‐Ann M. Burnett‐Bowie (ORCID: https://orcid.org/0000-0002-0064-096X)
- Gail A. Greendale (ORCID: https://orcid.org/0000-0003-1054-1081)
- Fatma Gossiel (ORCID: https://orcid.org/0000-0002-1433-2001)
- Albert Shieh (ORCID: https://orcid.org/0000-0002-0695-7976)
- Arun S. Karlamangla (ORCID: https://orcid.org/0000-0003-2293-6064)
- Richard Eastell (ORCID: https://orcid.org/0000-0002-0323-3366)
Institutions
- Harvard University (US)
- University of California, Los Angeles (US)
- Massachusetts General Hospital (US)
- University of Sheffield (GB)
Publication Details
- Journal
- The Journal of Clinical Endocrinology & Metabolism
- Published
- 2025-12-11
- DOI
- https://doi.org/10.1210/clinem/dgaf658
- Citations
- 1
- Primary Topic
- Menopause: Health Impacts and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.29